LoginSignup
DaVita logo

DaVita

Stock
Stock
Ticker: DVA
DVA

Price

Price

CHART BY

Frequently asked questions

The market capitalization of DaVita is $11.57B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for DaVita is 15.29. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
DaVita's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $11.86. EPS indicates the company's profitability on a per-share basis.
Currently, 10 analysts cover DaVita's stock, with a consensus target price of $227.33. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, DaVita reported a revenue of $14.01B.
DaVita's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $2.80B. EBITDA measures the company's overall financial performance.
DaVita has a free cash flow of $1.61B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
DaVita employs approximately 78,000 people. It operates in the Health Care sector, specifically within the Medical/ Nursing Services industry.
The free float of DaVita is 62.47M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$11.57B
EPS (TTM) 
$11.86
Free Float 
62.47M
P/E ratio (TTM) 
15.29
Revenue (TTM) 
$14.01B
EBITDA (TTM) 
$2.80B
Free Cashflow (TTM) 
$1.61B

Pricing

1D span
$180.69$184.13
52W span
$101.00$247.13

Analyst Ratings

The price target is $227.33 and the stock is covered by 10 analysts.

Buy

5

Hold

4

Sell

1

Information

DaVita, Inc. engages in the provision of medical care services. It operates through the US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives segments. The US Dialysis and Related Lab Services segment offer kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consists primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

Employees
78,000
Industries
Medical/ Nursing Services
Sector
Health Care

Identifier

Primary Ticker
DVA

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin